359 related articles for article (PubMed ID: 12654712)
1. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
Miura S; Matsuo Y; Saku K
Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
[TBL] [Abstract][Full Text] [Related]
2. [Transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor induces an angiogenic phenotype in human cultured coronary endothelial cells].
Miura S; Fujino M; Tanigawa H; Matsuo Y; Saku K
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):104P-105P. PubMed ID: 12491796
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).
Tanimoto T; Jin ZG; Berk BC
J Biol Chem; 2002 Nov; 277(45):42997-3001. PubMed ID: 12226078
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine-induced vascular endothelial growth factor secretion from coronary smooth muscle cells promotes endothelial tube formation via the kinase insert domain-containing receptor/fetal liver kinase-1/NO pathway.
Miura S; Fujino M; Matsuo Y; Tanigawa H; Saku K
Hypertens Res; 2005 Feb; 28(2):147-53. PubMed ID: 16025742
[TBL] [Abstract][Full Text] [Related]
5. Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells.
Thuringer D; Maulon L; Frelin C
J Biol Chem; 2002 Jan; 277(3):2028-32. PubMed ID: 11711543
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway.
Shen BQ; Lee DY; Zioncheck TF
J Biol Chem; 1999 Nov; 274(46):33057-63. PubMed ID: 10551875
[TBL] [Abstract][Full Text] [Related]
8. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
9. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
[TBL] [Abstract][Full Text] [Related]
10. VEGF-induced permeability increase is mediated by caveolae.
Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
[TBL] [Abstract][Full Text] [Related]
11. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
Kroll J; Waltenberger J
Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation.
Fujita Y; Yoshizumi M; Izawa Y; Ali N; Ohnishi H; Kanematsu Y; Ishizawa K; Tsuchiya K; Tamaki T
Endocrinology; 2006 Mar; 147(3):1377-85. PubMed ID: 16322069
[TBL] [Abstract][Full Text] [Related]
13. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.
Ushio-Fukai M; Tang Y; Fukai T; Dikalov SI; Ma Y; Fujimoto M; Quinn MT; Pagano PJ; Johnson C; Alexander RW
Circ Res; 2002 Dec; 91(12):1160-7. PubMed ID: 12480817
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
[TBL] [Abstract][Full Text] [Related]
15. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR).
Kroll J; Waltenberger J
Biochem Biophys Res Commun; 1998 Nov; 252(3):743-6. PubMed ID: 9837777
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin dilates rat middle cerebral artery and its large branches via endothelial B2 receptors and release of nitric oxide.
Görlach C; Wahl M
Peptides; 1996; 17(8):1373-8. PubMed ID: 8971934
[TBL] [Abstract][Full Text] [Related]
18. Flk-1 as a target for tumor growth inhibition.
Strawn LM; McMahon G; App H; Schreck R; Kuchler WR; Longhi MP; Hui TH; Tang C; Levitzki A; Gazit A; Chen I; Keri G; Orfi L; Risau W; Flamme I; Ullrich A; Hirth KP; Shawver LK
Cancer Res; 1996 Aug; 56(15):3540-5. PubMed ID: 8758924
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
20. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.
Chou MT; Wang J; Fujita DJ
BMC Biochem; 2002 Dec; 3():32. PubMed ID: 12509223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
